301206.SZ Stock Analysis
30
Uncovered
Shandong Sanyuan Biotechnology Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Shandong Sanyuan Biotechnology Co., Ltd. engages in the research and development, manufacture, and sale of erythritol and new multi-functional sweeteners. The company is headquartered in Binzhou, Shandong and currently employs 382 full-time employees. The company went IPO on 2022-02-10. The firm's main products are erythritol and compound sugar. The compound sugar products include momordica grosvenori compound sugar, stevia compound sugar, sucralose compound sugar and others. The firm's products are sold to America, Europe, Africa, Oceania and other regions.